[Adjuvant chemotherapy in cancers of the stomach, pancreas and intestine].

Abstract:

:Adjuvant chemotherapy after apparently complete resection of gastrointestinal cancer may be theoretically justified by the high rate of local and metastatic recurrences. However, the results of controlled trials are generally disappointing, even if some of them have recently suggested some hope, chiefly for adjuvant therapy in gastric cancer. Confirmation of these preliminary results is needed before considering adjuvant therapy as routine treatment in digestive tumors.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Martin F

subject

Has Abstract

pub_date

1984-01-01 00:00:00

pages

374-6

issue

4

eissn

0007-4551

issn

1769-6917

journal_volume

71

pub_type

杂志文章
  • [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects].

    abstract::Cerebral non Hodgkin's lymphomas (NHL) of immunocompetent patients are rare disease (1% of all NHL), but their incidence has been steadily increasing in the last 20 years. Most cerebral NHL are diffuse large cell NHL with a B phenotype. These tumors are most often localized in the central nervous system, the eye or me...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,meta分析

    doi:

    authors: Blay JY

    更新日期:1997-10-01 00:00:00

  • [Genetic counseling in cancerology].

    abstract::The evidence that genetic factors are of some importance in the etiology of cancer originates has been determined by genetic epidemiology, molecular biology, cytogenetics. Genetic counselling is one of the possible strategies for controlling cancer through genetics. Genetic counselling in this field more often concern...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Feingold J

    更新日期:1991-01-01 00:00:00

  • Is the proportion of hypoxic cells in a solid tumour dependent on the host (mouse or rat)?

    abstract::Hypoxic cell fraction was measured in a human tumour xenografted on two different animal species: mouse and rat. These results suggest that, while the Na11 tumour response to radiation depends on the host (nude mouse, nude rat), the proportion of hypoxic cells tested with the growth delay assay is independent of the h...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Guichard M,Chavaudra N,Malaise EP

    更新日期:1989-01-01 00:00:00

  • [Unresolved questions in the indications for the conservative treatment of invasive cancer of the breast].

    abstract::The majority of patients with breast cancer can be treated by partial mastectomy and radiation therapy. The choice of the treatment involves the estimation of the risk for intramammary recurrence and the ability to achieve satisfactory cosmetic result. Patient selection in breast conserving therapy is dependent on cli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Zinzindohoué C,Bobin JY

    更新日期:1998-09-01 00:00:00

  • [Clinical activity spectrum of irinotecan].

    abstract::Irinotecan (CPT11), a topoisomerase I inhibitor, is a new cytotoxic agent with a broad spectrum of clinical activity. Two main schedules have been studied and produce similar activity and side-effects: the "european" one--350 mg/m2 every 21 days-, and the "japanese-north american" one where CPT11 is given at a weekly ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cottu PH,Extra JM,Lerebours F,Espie M,Marty M

    更新日期:1998-12-01 00:00:00

  • [Cognitive impairments and breast cancer: a critical review of the literature].

    abstract::Since the 1980's, women treated for breast cancer are reporting moderate cognitive impairments during and after chemotherapy. These cognitive impairments may be related to chemotherapy but also to hormone therapy, psychological distress, fatigue... This work is a critical review of the literature, which reports types ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0818

    authors: Vandenbossche S,Fery P,Razavi D

    更新日期:2009-02-01 00:00:00

  • Infectious complications associated with granulocytopenia during the treatment of poor risk or relapsed germ cell tumors.

    abstract::Infectious complications associated with granulocytopenia during the treatment of poor risk or relapsed germ cell tumors were studied in order to assess the frequency, morbidity and characteristics of these complications. Thirty-three cases were investigated at the Institut Gustave-Roussy; 63 episodes of granulocytope...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Ribrag V,Droz JP,Kattan J,Andremont A

    更新日期:1992-01-01 00:00:00

  • [Detection and evaluation of malnutrition in oncology: What tools, what type of cancer and for what purposes?].

    abstract::Malnutrition is frequently observed in oncology. The consequences on patient survival, chemotherapy toxicities and quality of life need to be identified and treated appropriately. A set of tools are available that enable clinicians to diagnose and detect malnutrition. Each tool must consider three items: the patient's...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.06.003

    authors: Khan S,Alibay TA,Merad M,DiPalma M,Raynard B,Antoun S

    更新日期:2016-09-01 00:00:00

  • [Sarcomas of soft tissue in the adult. Therapeutical indications].

    abstract::Treatment of soft-tissue sarcomas has to deal simultaneously with three goals: 1) to obtain the control of the primary tumor, 2) to preserve the function, and 3) to treat the micrometastatic disease. For local control, surgery remains the most efficient treatment, but the extent of the resection of macroscopically non...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bui NB

    更新日期:1988-01-01 00:00:00

  • [Characterization of chromosomal rearrangements by in situ hybridization in glioblastoma].

    abstract::In a case of glioblastoma, the following karyotype was determined: 47, X, - Y, + der(1) t(1;9)(p21;p23), t(1;9)(p21;p23), + 3, + 7, der(9) t(Y;9)(q11;p21), - 13, t(13;16)(p13,p11), del(14)(q11q22). Classical satellite DNAs are mainly located in chromosomes 1, 9, 15, 16 and Y. Because, most of these chromosomes were im...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bourgeois CA,Kokalj-Vokac N,Dutrillaux AM,Poisson M,Delattre JY,Vega F,Malfoy B,Dutrillaux B

    更新日期:1994-05-01 00:00:00

  • Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.

    abstract:BACKGROUND:The standard treatment in first line of advanced or metastatic urothelial bladder cancer (MBC) is the association of Gemcitabine and Cisplatin (GC). Avelumab, an anti-PD-L1 agent, has recently demonstrated efficacy. The objective is to evaluate the combination of these 3 agents. METHODS:This phase II random...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30280-0

    authors: Gross-Goupil M,Domblides C,Lefort F,Ravaud A

    更新日期:2020-06-01 00:00:00

  • [Pharmacological consequences of the targeting of epidermal growth factor receptor].

    abstract::Through clearly identified molecular mechanisms, EGFR targeting leads to cell physiology modifications as cell proliferation, apoptosis and DNA repair. These mechanisms can explain the proper activity of EGFR targeting drugs but also represent a strong rational basis on which several experimental studies have been des...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Milano G,Magné N

    更新日期:2003-11-01 00:00:00

  • [Gene therapy of primary cancers of the liver: hopes and realities].

    abstract::Many efforts have been devoted to the development of gene therapy for primary liver tumors. This has been hampered by the absence of efficient gene transfer vectors for delivering genes into hepatoma cells in vivo. Also it remains to determine which type of gene has to be used to achieve complete tumor regression. Rec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Ferry N

    更新日期:1997-04-01 00:00:00

  • The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.

    abstract:BACKGROUND AND AIM:CABYR, a calcium-binding tyrosine phosphorylation regulated fibrous sheath protein, was initially reported to be testis-specific and subsequently shown to be present in brain tumors, pancreas cancer and lung cancer. This study aimed to investigate the expression and effects of the CABYR-c transcript ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2011.1538

    authors: Li H,Fang L,Xiao X,Shen L

    更新日期:2012-03-01 00:00:00

  • [The surrogate: Partner in the shared decision-making].

    abstract:UNLABELLED:The legislative process of the surrogate appears to be unclear to health professionals and to patients and next of kin. To better adapt this process to the clinical practice our objective was here to document how the persons designated as surrogate perceived their role and how they described the difficulties...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.03.003

    authors: Sarradon-Eck A,Capodano G,Bureau E,Julian-Reynier C

    更新日期:2016-07-01 00:00:00

  • [Is bone scan useful in patients with breast cancer localized on the basis of clinical examination. 143 cases (author's transl)].

    abstract::The authors present 143 cases of breast carcinoma T1 and T2, N0, N1, N2 and N3 without clinical signs of bone metastasis. They study the value of bone scintigraphy with technetium 99m labelled diphosphonates. One hundred and twelve patients had normal bone scans; 31 patiets showed abnormal fixation sites: in 23 (16%) ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Stines J,Stalars J,Dartois D,Chardot C

    更新日期:1980-01-01 00:00:00

  • [Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines].

    abstract:INTRODUCTION:The last years are marked by the emergence of new molecules for the treatment of metastatic cutaneous melanoma with a significant benefit on the survival. Besides, some techniques are in development for the loco-regional treatment of the metastatic sites, bringing new therapeutic perspectives. However, the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引

    doi:10.1684/bdc.2013.1868

    authors: Sassolas B,Mourrégot A,Thariat J,Tiffet O,Dygai-Cochet I,Mirabel X,Truc G,Cupissol D,Modiano P,Combemale P,Bedane C,Derrey S,Lamant L,Lubrano V,Siegrist S,Rougé-Bugat MÈ,Mazeau-Woynar V,Verdoni L,Planchamp F,Leccia

    更新日期:2014-01-01 00:00:00

  • [Epidemiology and anatomy of head and neck cancers].

    abstract::Oral cavity and pharyngeal cancers account for 75% of head and neck cancers and are the fourth most spread cancer in men. Their incidence has decreased since 1980 in men (incidence from 2011 gives 13,930 for lip, oral cavity, pharyngeal and laryngeal carcinomas) but has increased in women, linked to the more recent sm...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1962

    authors: Périé S,Meyers M,Mazzaschi O,De Crouy Chanel O,Baujat B,Lacau St Guily J

    更新日期:2014-05-01 00:00:00

  • [Patients and the Web].

    abstract::In recent years, Internet has become an indispensable tool for all types of information. Its importance has increased in medicine and particularly in human malignancies. The data issued by the Internet are many and varied sources ranging from official websites to patient's blogs. HIV infection is an infection highly p...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1160

    authors: Cluzeau T,Mounier N

    更新日期:2010-10-01 00:00:00

  • Cost-effectiveness analysis for clinical procedures in oncology.

    abstract::The provision of medical care consumes resources, and the resources available for the provision of medical care are limited. Decisions are being made at many levels of the Health Care System, including providers and fiscal intermediaries, to allocate these resources. Such decisions, however, are often inconsistent wit...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Weinstein MC

    更新日期:1980-01-01 00:00:00

  • [Immune-checkpoints: the new anti-cancer immunotherapies].

    abstract::The immune system plays a dual role against cancer: it prevents tumor cell outgrowth and also sculpts the immunogenicity of the tumor cells. Cancer cells are able to escape from the immune system by inhibiting T lymphocytes activation. New immunotherapies have been developped to target these T lymphocytes activation m...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1771

    authors: Ileana E,Champiat S,Soria JC

    更新日期:2013-06-01 00:00:00

  • Immunothérapie des glioblastomes.

    abstract:IMMUNOTHERAPY IN GLIOBLASTOMAS:Targeting the immune system as a therapeutic strategy in solid tumors has shown great efficacy in various tumor types. However the role and success of this approach in glioblastomas remain to be determined. Recent studies demonstrated that central nervous system is no longer considered as...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(18)30391-6

    authors: Baldini C,Romano PM,Varga A,Champiat S,Dumont S,Dhermain F,Louvel G,Marabelle A,Postel-Vinay S,Angevin E,Gazzah A,Ribrag V,Bahleda R,Michot JM,Hollebecque A,Soria JC,Massard C

    更新日期:2018-12-01 00:00:00

  • [Role of interleukin 6 in hepatocellular carcinoma].

    abstract::Interleukin 6 (IL-6) is a pleiotropic cytokine which possesses a broad spectrum of action in diverse pathological conditions. It is mainly produced and metabolised in the liver where it carries out one of its best known actions in the mediation of the acute phase response. We studied its behaviour in hepatocellular ca...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Malaguarnera M,Di Fazio I,Laurino A,Romeo MA,Giugno I,Trovato BA

    更新日期:1996-05-01 00:00:00

  • [Radiotherapy for sarcoma: hadrontherapy, for whom and what for?].

    abstract::The radiobiological properties of the hadrons (neutrons, protons, carbon ions) led to their therapeutic use in sarcomas, as a referent therapy or as an alternative to photon therapy. An extensive review of the literature has been conducted to assess the present indications and the perspectives for hadrontherapy. Compa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1125

    authors: Pommier P,Sunyach MP,Hu Y,Amsalem E,Claude L,Moncort-Boulch D,Toutenu P,Balosso J

    更新日期:2010-06-01 00:00:00

  • [Low dose cytarabine in the treatment of acute myeloid leukemia. Apropos of 41 cases].

    abstract::This is a retrospective study on the use of cytarabine at low doses in acute myeloid leukemias in 41 patients. Four groups of AML are included: group A: 19 cases of de novo AML in elderly patients; group B: ten cases of AML in relapse; group C: five cases of AML refractory to previous treatment and group D: seven case...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Frikha M,Elloumi M,Bouaziz M,Daoud J,Mseddi S,Khanfir A,Gargouri J,Souissi T

    更新日期:1996-12-01 00:00:00

  • [Image guided radiation therapy (IGRT)].

    abstract::Image guided radiation therapy (IGRT) is a major technical innovation of radiotherapy. It allows locating the tumor under the linear accelerator just before the irradiation, by direct visualization (3D mode soft tissue) or indirect visualization (2D mode and radio-opaque markers). The technical implementation of IGRT ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1140

    authors: Lagrange JL,de Crevoisier R

    更新日期:2010-07-01 00:00:00

  • [Small cell bronchial cancer: epidemiology].

    abstract::Small cell lung carcinoma is the most frequent cancer in man. In France, the geographic distribution is not homogenous and the frequency is time-dependent. The main risk factors are smoking and some professional exposures. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Flamant R,Hill C,Benhamou S

    更新日期:1987-01-01 00:00:00

  • [Urinary incontinence and sexual dysfunction after treatment of localized prostate cancer: Results from a population aged less than 65years old].

    abstract:INTRODUCTION:An increasing number of patients with prostate cancer (PC) are diagnosed and treated. The aim of this study was to investigate urinary incontinence (UI) and sexual dysfunction (SD) two years after treatment for localized prostate cancer (PC). METHODS:This study followed all cases of localized PC diagnosed...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.09.011

    authors: Bessaoud F,Orsini M,Iborra F,Rebillard X,Faix A,Soulier M,Daurès JP,Trétarre B

    更新日期:2016-10-01 00:00:00

  • [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].

    abstract::For most diseases, one observes great variability in clinical course and response to therapy which should be taken into account in the design and the analysis of clinical trials. Eligibility criteria and stratified randomization use prognostic knowledge. A suitable analysis of randomized studies includes: (1) checking...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Byar D,Chastang C

    更新日期:1987-01-01 00:00:00

  • [What do we know about ATM protein expression in breast tissue?].

    abstract::The great majority of breast cancer cases are not associated with a mutated gene of high penetrance such as BRCA1, BRCA2 and TP53. Genes of low penetrance, frequently mutated in the general population, might play an important role in breast cancer development. The ATM gene, which encodes the ATM protein, mutated in th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Angèle S,Tanière P,Hall J

    更新日期:2001-07-01 00:00:00